| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Pept_M10A_Zn_BS | 1.32e-04 | 15 | 127 | 3 | IPR021158 | |
| Domain | Pept_M10A_stromelysin-type | 2.33e-04 | 18 | 127 | 3 | IPR016293 | |
| Domain | PG_binding_1 | 3.22e-04 | 20 | 127 | 3 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 3.22e-04 | 20 | 127 | 3 | IPR002477 | |
| Domain | Hemopexin-like_dom | 4.92e-04 | 23 | 127 | 3 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 4.92e-04 | 23 | 127 | 3 | IPR018487 | |
| Domain | HEMOPEXIN | 4.92e-04 | 23 | 127 | 3 | PS00024 | |
| Domain | - | 4.92e-04 | 23 | 127 | 3 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 4.92e-04 | 23 | 127 | 3 | PS51642 | |
| Domain | HX | 4.92e-04 | 23 | 127 | 3 | SM00120 | |
| Domain | M10A_MMP | 4.92e-04 | 23 | 127 | 3 | IPR033739 | |
| Domain | Hemopexin | 4.92e-04 | 23 | 127 | 3 | PF00045 | |
| Domain | Pept_M10A | 4.92e-04 | 23 | 127 | 3 | IPR021190 | |
| Domain | Peptidase_M10 | 5.60e-04 | 24 | 127 | 3 | PF00413 | |
| Domain | Peptidase_Metallo | 9.86e-04 | 29 | 127 | 3 | IPR006026 | |
| Domain | ZnMc | 9.86e-04 | 29 | 127 | 3 | SM00235 | |
| Domain | - | 2.26e-03 | 81 | 127 | 4 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.26e-03 | 81 | 127 | 4 | IPR024079 | |
| Domain | CYSTEINE_SWITCH | 2.71e-03 | 41 | 127 | 3 | PS00546 | |
| Domain | Oxysterol-bd_CS | 2.90e-03 | 12 | 127 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 2.90e-03 | 12 | 127 | 2 | PF01237 | |
| Domain | Oxysterol-bd | 2.90e-03 | 12 | 127 | 2 | IPR000648 | |
| Domain | OSBP | 2.90e-03 | 12 | 127 | 2 | PS01013 | |
| Domain | Ser/Thr_kinase_AS | 3.08e-03 | 357 | 127 | 8 | IPR008271 | |
| Domain | Pept_M10_metallopeptidase | 3.11e-03 | 43 | 127 | 3 | IPR001818 | |
| Domain | S_TKc | 3.18e-03 | 359 | 127 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 3.35e-03 | 362 | 127 | 8 | PS00108 | |
| Domain | PROTEIN_KINASE_ATP | 4.16e-03 | 459 | 127 | 9 | PS00107 | |
| Domain | Protein_kinase_ATP_BS | 4.41e-03 | 379 | 127 | 8 | IPR017441 | |
| Domain | ZINC_PROTEASE | 4.50e-03 | 98 | 127 | 4 | PS00142 | |
| Domain | Pkinase | 4.55e-03 | 381 | 127 | 8 | PF00069 | |
| Domain | Hemopexin_CS | 5.84e-03 | 17 | 127 | 2 | IPR018486 | |
| Domain | Acyl_Trfase/lysoPLipase | 5.84e-03 | 17 | 127 | 2 | IPR016035 | |
| Domain | Prot_kinase_dom | 6.25e-03 | 489 | 127 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 6.58e-03 | 493 | 127 | 9 | PS50011 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.35e-06 | 87 | 98 | 7 | M12467 | |
| Pathway | WP_ERBB_SIGNALING | 3.42e-06 | 92 | 98 | 7 | M39715 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 5.16e-05 | 11 | 98 | 3 | M27420 | |
| Pubmed | KIF13B TCAF1 CMTR1 RNPC3 GNB1L EPB41L3 WDFY4 CASZ1 PWWP2A USF3 DTX2 MGA HERPUD1 | 4.63e-08 | 493 | 130 | 13 | 15368895 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 15654517 | ||
| Pubmed | KIF13B AKT3 TCAF1 SETX NRDC PEG3 APC PSMD1 PRAMEF4 RBM28 WDFY4 BRAF DTX2 MMP1 MGA STK24 BRWD1 | 6.51e-07 | 1084 | 130 | 17 | 11544199 | |
| Pubmed | AKT3 APC MMP20 DMXL1 ACSM3 DPP9 BRAF BRDT KCNC4 RNF20 PRKCB OXSR1 MMP1 MMP13 | 6.61e-07 | 730 | 130 | 14 | 34857952 | |
| Pubmed | 2.31e-06 | 486 | 130 | 11 | 20936779 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN SLC37A1 SPTB RTN4RL1 PSMD1 PPM1K CASZ1 USF3 DPP9 KCNQ5 SUGP2 RPF2 ANTXR1 OS9 CACNA1H OXSR1 PACRG MAP2K3 PDZD2 | 2.92e-06 | 1489 | 130 | 19 | 28611215 |
| Pubmed | Systematic identification of molecular links between core and candidate genes in breast cancer. | 8.93e-06 | 194 | 130 | 7 | 25640309 | |
| Pubmed | 1.15e-05 | 371 | 130 | 9 | 25241761 | ||
| Pubmed | Systemic Therapy Options for Patients With Unresectable Melanoma. | 1.39e-05 | 2 | 130 | 2 | 28561662 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 31743419 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21539914 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29464327 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18006830 | ||
| Pubmed | Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. | 1.39e-05 | 2 | 130 | 2 | 18451171 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 32669376 | ||
| Pubmed | The immunoexpression of MMP-1 and MMP-13 in eyelid basal cell carcinoma. | 1.39e-05 | 2 | 130 | 2 | 34171070 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19787068 | ||
| Pubmed | Suppressed Expression but Not Activity of Collagenases MMP-1 and MMP-13 in Human Renal Carcinoma. | 1.39e-05 | 2 | 130 | 2 | 31129674 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20826465 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28262727 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19378335 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18597171 | ||
| Pubmed | Genetic screening of MMP1 as a potential pathogenic gene in chronic obstructive pulmonary disease. | 1.39e-05 | 2 | 130 | 2 | 36442527 | |
| Pubmed | Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells. | 1.39e-05 | 2 | 130 | 2 | 20647317 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21144496 | ||
| Pubmed | Ubiquitylation-dependent downregulation of Nck regulates its functional activity. | 1.39e-05 | 2 | 130 | 2 | 25218436 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35742953 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18755271 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17697361 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14764579 | ||
| Pubmed | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. | 1.39e-05 | 2 | 130 | 2 | 29669932 | |
| Pubmed | Influence of sex chromosome constitution on the genomic imprinting of germ cells. | 1.39e-05 | 2 | 130 | 2 | 16847261 | |
| Pubmed | Distinct biological events generated by ECM proteolysis by two homologous collagenases. | 1.39e-05 | 2 | 130 | 2 | 27630193 | |
| Pubmed | Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. | 1.39e-05 | 2 | 130 | 2 | 15630448 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21170377 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19902888 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23902766 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21199875 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21451543 | ||
| Pubmed | Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis. | 1.39e-05 | 2 | 130 | 2 | 25863779 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25899612 | ||
| Pubmed | MMP-1 drives immunopathology in human tuberculosis and transgenic mice. | 1.39e-05 | 2 | 130 | 2 | 21519144 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28444112 | ||
| Pubmed | A functional polymorphism in MMP1 could influence osteomyelitis development. | 1.39e-05 | 2 | 130 | 2 | 19821768 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12009332 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11280766 | ||
| Pubmed | 1.87e-05 | 497 | 130 | 10 | 23414517 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B RBM15 SETX PAK5 APC EPB41L3 AKAP9 KCNQ5 BRAF NCOA7 NR3C2 MAP2K7 MUSK | 2.19e-05 | 861 | 130 | 13 | 36931259 |
| Pubmed | 2.39e-05 | 407 | 130 | 9 | 12693553 | ||
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 2.76e-05 | 16 | 130 | 3 | 29878059 | |
| Pubmed | 2.76e-05 | 16 | 130 | 3 | 20484597 | ||
| Pubmed | RBM15 PSMD1 RBM28 EPB41L3 LONP1 FASN IARS2 SUGP2 MDC1 RPF2 ZMYM3 | 3.63e-05 | 653 | 130 | 11 | 22586326 | |
| Pubmed | Loss of NEDD4 causes complete XY gonadal sex reversal in mice. | 4.00e-05 | 18 | 130 | 3 | 35075134 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19147581 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 31264811 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 30115035 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19608765 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 25527274 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 38732103 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 34969747 | ||
| Pubmed | Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis. | 4.15e-05 | 3 | 130 | 2 | 19296842 | |
| Pubmed | Oxytocin prevents cartilage matrix destruction via regulating matrix metalloproteinases. | 4.15e-05 | 3 | 130 | 2 | 28238786 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 32792685 | ||
| Pubmed | Expression of SRY proteins in both normal and sex-reversed XY fetal mouse gonads. | 4.15e-05 | 3 | 130 | 2 | 15789443 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 25856795 | ||
| Pubmed | Collagenase expression and activity in the stromal cells from giant cell tumour of bone. | 4.15e-05 | 3 | 130 | 2 | 19442604 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 26351322 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 38527983 | ||
| Pubmed | Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway. | 4.15e-05 | 3 | 130 | 2 | 24444033 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 21039987 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 16630131 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 25681634 | ||
| Pubmed | Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. | 4.15e-05 | 3 | 130 | 2 | 10987272 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 23814055 | ||
| Pubmed | Site-specific use of molecular markers could be a promising prognostic tool in colorectal cancer. | 4.15e-05 | 3 | 130 | 2 | 29745066 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 12189188 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 20570909 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 32024448 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 21591259 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 14558091 | ||
| Pubmed | Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias. | 4.15e-05 | 3 | 130 | 2 | 27207659 | |
| Pubmed | Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. | 4.15e-05 | 3 | 130 | 2 | 19094243 | |
| Pubmed | Matrix metalloproteinases MMP-1, MMP-2, and MMP-13 are overexpressed in primary nodular melanoma. | 4.15e-05 | 3 | 130 | 2 | 31677173 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 12743109 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 8609233 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 31974474 | ||
| Pubmed | The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay. | 4.15e-05 | 3 | 130 | 2 | 31950173 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18366705 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18450749 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 29540530 | ||
| Pubmed | Acute ether lipid deficiency affects neutrophil biology in mice. | 4.15e-05 | 3 | 130 | 2 | 25955199 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18992635 | ||
| Pubmed | Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. | 4.15e-05 | 3 | 130 | 2 | 12941808 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17546626 | ||
| Pubmed | SHARPIN negatively associates with TRAF2-mediated NFκB activation. | 4.73e-05 | 19 | 130 | 3 | 21829440 | |
| Pubmed | FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue. | 4.73e-05 | 19 | 130 | 3 | 34348145 | |
| Pubmed | Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromes. | 6.46e-05 | 21 | 130 | 3 | 32452519 | |
| Pubmed | 6.46e-05 | 463 | 130 | 9 | 27503909 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 7.46e-05 | 22 | 130 | 3 | 23421805 | |
| Pubmed | 7.46e-05 | 22 | 130 | 3 | 10419448 | ||
| Cytoband | 1p21 | 4.30e-05 | 24 | 130 | 3 | 1p21 | |
| Cytoband | 11q22.3 | 2.70e-04 | 44 | 130 | 3 | 11q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 6.99e-04 | 140 | 130 | 4 | chr2p13 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.02e-04 | 24 | 87 | 3 | 891 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 4.73e-04 | 7 | 87 | 2 | 653 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.46e-03 | 12 | 87 | 2 | 670 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN | 6.92e-06 | 200 | 129 | 8 | M4027 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ABCA1 GON4L CBLB PTGS1 SNN OSBP OSBPL2 AKAP9 ST3GAL6 LYPD3 MMP1 MMP13 HERPUD1 PDZD2 BRWD1 | 1.33e-05 | 822 | 129 | 15 | M6782 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | CMTR1 RNPC3 RBM26 APC PEX12 PSMD1 FASN MDC1 RNF20 PNPLA8 DSCC1 STK24 BRWD1 | 2.43e-05 | 564 | 123 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_500 | 3.85e-05 | 33 | 123 | 4 | gudmap_developingGonad_P2_ovary_500_k5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-07 | 178 | 130 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 180 | 130 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.57e-06 | 192 | 130 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.62e-06 | 193 | 130 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 195 | 130 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 195 | 130 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-06 | 199 | 130 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.87e-06 | 135 | 130 | 6 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.36e-05 | 177 | 130 | 6 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 179 | 130 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 179 | 130 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 182 | 130 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.74e-05 | 185 | 130 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 187 | 130 | 6 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.02e-05 | 190 | 130 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.09e-05 | 191 | 130 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.09e-05 | 191 | 130 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.28e-05 | 194 | 130 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.28e-05 | 194 | 130 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 195 | 130 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.34e-05 | 195 | 130 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-05 | 196 | 130 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 2.48e-05 | 197 | 130 | 6 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 130 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-05 | 198 | 130 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.63e-05 | 199 | 130 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.70e-05 | 200 | 130 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.19e-05 | 124 | 130 | 5 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.13e-05 | 137 | 130 | 5 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 139 | 130 | 5 | b07929348ec9ad95d7bce33a7deac0938227b19f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.94e-05 | 146 | 130 | 5 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.40e-05 | 152 | 130 | 5 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 165 | 130 | 5 | 4f95c2fe5ab4416c736fe0d1936695a2b26777eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 165 | 130 | 5 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 165 | 130 | 5 | 3e913b49a868fdd5589200ae3e9be77c0938ba14 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 167 | 130 | 5 | 2dc3de562a26077cb76855b725cf278a272d3276 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 1.38e-04 | 169 | 130 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.38e-04 | 169 | 130 | 5 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 170 | 130 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 170 | 130 | 5 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 1.42e-04 | 170 | 130 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.46e-04 | 171 | 130 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 171 | 130 | 5 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 173 | 130 | 5 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 173 | 130 | 5 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 173 | 130 | 5 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 174 | 130 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 93 | 130 | 4 | af489f0dd76c3c1a84d164283149f550a7ece91c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 93 | 130 | 4 | c1d0afcfa37c2dcbb12189b4ce56ae7c4bb7ba30 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 93 | 130 | 4 | 0ea74c2820372d60d3804bf2c8bb0d03733dff98 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 175 | 130 | 5 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 175 | 130 | 5 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 175 | 130 | 5 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 175 | 130 | 5 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 176 | 130 | 5 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 176 | 130 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 177 | 130 | 5 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-04 | 178 | 130 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 178 | 130 | 5 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 178 | 130 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-04 | 178 | 130 | 5 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 178 | 130 | 5 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-04 | 178 | 130 | 5 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 179 | 130 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 179 | 130 | 5 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 180 | 130 | 5 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-04 | 181 | 130 | 5 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.00e-04 | 183 | 130 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 184 | 130 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 184 | 130 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 184 | 130 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 184 | 130 | 5 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 184 | 130 | 5 | 73ddf9d647d61381bab1e9c0d983736b6d390c15 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.10e-04 | 185 | 130 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | (05)_Secretory-(1)_GFP|(05)_Secretory / shred by cell type by condition | 2.11e-04 | 100 | 130 | 4 | 838340a2b7c76f603e0ef2fe4fd170bd0dbce685 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 186 | 130 | 5 | 124a618a0911aba9fc2a071dc3ca40fc003bb1ed | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 186 | 130 | 5 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 186 | 130 | 5 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-04 | 186 | 130 | 5 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 186 | 130 | 5 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.21e-04 | 187 | 130 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-04 | 187 | 130 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 187 | 130 | 5 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 188 | 130 | 5 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 2.32e-04 | 189 | 130 | 5 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| Drug | choline | ABCA1 FMO4 ENPP2 FBF1 APC OSBPL2 ST3GAL6 PNPLA8 HERPUD1 MUSK | 1.19e-05 | 320 | 126 | 10 | CID000000305 |
| Drug | 6-Mna | 1.36e-05 | 9 | 126 | 3 | CID000030861 | |
| Drug | 6MNA | 1.36e-05 | 9 | 126 | 3 | CID000032176 | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.43e-05 | 197 | 126 | 8 | 4161_UP | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 7551_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 126 | 8 | 5604_UP | |
| Disease | Colorectal Carcinoma | DNAH3 ABCA1 PEG3 APC BRINP1 ADAMTSL3 OSBP AKAP9 KCNQ5 BRAF PRKCB NR3C2 MMP1 | 7.82e-06 | 702 | 123 | 13 | C0009402 |
| Disease | interstitial collagenase measurement | 1.14e-05 | 11 | 123 | 3 | EFO_0008193 | |
| Disease | obstructive lung disease (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:2320 (is_implicated_in) | |
| Disease | 4-hydroxyphenylacetylglutamine measurement | 5.16e-05 | 3 | 123 | 2 | EFO_0800688 | |
| Disease | Adenocarcinoma of large intestine | 5.24e-05 | 96 | 123 | 5 | C1319315 | |
| Disease | mean corpuscular hemoglobin concentration | ATMIN CYP26B1 SPTB GON4L CYRIB DMXL1 LONP1 BRDT RNF20 ANTXR1 OXSR1 MAP2K3 MAP2K7 MUSK SENP7 | 5.83e-05 | 1105 | 123 | 15 | EFO_0004528 |
| Disease | stomach carcinoma (is_marker_for) | 1.34e-04 | 24 | 123 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Intestinal Polyps | 1.71e-04 | 5 | 123 | 2 | C0021846 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:2) in blood serum | 2.56e-04 | 6 | 123 | 2 | OBA_2045134 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:2) in blood serum | 2.56e-04 | 6 | 123 | 2 | OBA_2045114 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:8577 (implicated_via_orthology) | |
| Disease | degenerative disc disease (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | carotid plaque build | 4.29e-04 | 84 | 123 | 4 | EFO_0006501 | |
| Disease | matrix metalloproteinase 7 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0010591 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0800610 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0800396 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0800423 | |
| Disease | X-17676 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0800785 | |
| Disease | oral microbiome measurement | 7.21e-04 | 42 | 123 | 3 | EFO_0801229 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 7.59e-04 | 10 | 123 | 2 | OBA_2045132 | |
| Disease | body fat percentage | 1.04e-03 | 488 | 123 | 8 | EFO_0007800 | |
| Disease | uric acid measurement | 1.06e-03 | 610 | 123 | 9 | EFO_0004761 | |
| Disease | Kidney Failure, Chronic | 1.07e-03 | 48 | 123 | 3 | C0022661 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.11e-03 | 12 | 123 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0800500 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0800466 | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.11e-03 | 12 | 123 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.14e-03 | 616 | 123 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.14e-03 | 616 | 123 | 9 | C0376358 | |
| Disease | Congestive heart failure | 1.18e-03 | 110 | 123 | 4 | C0018802 | |
| Disease | Heart failure | 1.18e-03 | 110 | 123 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.18e-03 | 110 | 123 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.18e-03 | 110 | 123 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.18e-03 | 110 | 123 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.18e-03 | 110 | 123 | 4 | C1959583 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.27e-03 | 51 | 123 | 3 | EFO_0022285 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.30e-03 | 13 | 123 | 2 | OBA_2045072 | |
| Disease | reticulocyte count | ABCA1 SPTB PEX12 PLPPR3 CYRIB OSBPL2 ANTXR1 NCOA7 BSN MMP13 MAP2K3 PDZD2 | 1.43e-03 | 1045 | 123 | 12 | EFO_0007986 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.52e-03 | 14 | 123 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.52e-03 | 14 | 123 | 2 | OBA_2045100 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.58e-03 | 55 | 123 | 3 | EFO_0022288 | |
| Disease | matrix metalloproteinase 1 measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0010588 | |
| Disease | phosphatidylcholine 36:3 measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0010381 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.75e-03 | 15 | 123 | 2 | OBA_2045131 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.75e-03 | 15 | 123 | 2 | OBA_2045067 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 1.75e-03 | 15 | 123 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.99e-03 | 16 | 123 | 2 | OBA_2045090 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.03e-03 | 60 | 123 | 3 | EFO_0022282 | |
| Disease | lysophosphatidylcholine measurement | 2.23e-03 | 62 | 123 | 3 | EFO_0010224 | |
| Disease | Benign neoplasm of stomach | 2.25e-03 | 17 | 123 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.25e-03 | 17 | 123 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.25e-03 | 17 | 123 | 2 | C0154060 | |
| Disease | body weight | MTIF3 ADAMTS3 PAK5 GON4L RTN4RL1 BRINP1 ADAMTSL3 FASN USF3 KCNQ5 MGA UNC79 PDZD2 | 2.36e-03 | 1261 | 123 | 13 | EFO_0004338 |
| Disease | spine bone size | 2.52e-03 | 18 | 123 | 2 | EFO_0004508 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 2.52e-03 | 18 | 123 | 2 | OBA_2045065 | |
| Disease | total lipids in very large HDL measurement | 2.67e-03 | 66 | 123 | 3 | EFO_0022312 | |
| Disease | Pancreatic carcinoma | 2.81e-03 | 19 | 123 | 2 | C0235974 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 2.81e-03 | 19 | 123 | 2 | OBA_2045179 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0802076 | |
| Disease | cholesterol in very large HDL measurement | 3.03e-03 | 69 | 123 | 3 | EFO_0022229 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.03e-03 | 69 | 123 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.12e-03 | 20 | 123 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | coagulation factor V measurement | 3.12e-03 | 20 | 123 | 2 | EFO_0008087 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.12e-03 | 20 | 123 | 2 | OBA_2045071 | |
| Disease | COVID-19 (is_implicated_in) | 3.44e-03 | 21 | 123 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 3.44e-03 | 21 | 123 | 2 | C0699791 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 3.44e-03 | 21 | 123 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 3.44e-03 | 21 | 123 | 2 | OBA_2045083 | |
| Disease | phospholipids in large HDL measurement | 3.55e-03 | 73 | 123 | 3 | EFO_0022190 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.77e-03 | 22 | 123 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | progression free survival, ovarian serous carcinoma | 3.77e-03 | 22 | 123 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | triacylglycerol 54:6 measurement | 3.77e-03 | 22 | 123 | 2 | EFO_0010424 | |
| Disease | JT interval | 3.90e-03 | 248 | 123 | 5 | EFO_0007885 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.91e-03 | 153 | 123 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.91e-03 | 153 | 123 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 4.12e-03 | 23 | 123 | 2 | OBA_2045181 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 4.12e-03 | 23 | 123 | 2 | EFO_0006919, GO_1903493 | |
| Disease | malignant astrocytoma (is_marker_for) | 4.12e-03 | 23 | 123 | 2 | DOID:3069 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KCIIAMGLDKKPSLP | 396 | Q5RHP9 | |
| PDLSKVRSNCPKAMK | 676 | P15056 | |
| SKKACMFEPLPIKLS | 2761 | Q99996 | |
| KDGLLKPTCGMKISL | 766 | Q9BXX2 | |
| KPTCGMKISLPNKAL | 771 | Q9BXX2 | |
| CPAPILKEVGMKAAL | 281 | Q9H6X2 | |
| TKKPDNVPKCDEILM | 896 | Q5VTR2 | |
| PLEAKLIKDPTMQCK | 86 | Q96LI9 | |
| KKLISCPGMPSKEQR | 461 | Q9NQI0 | |
| APGKPQLDLFSCMLK | 711 | O60477 | |
| NVKKMKNECIPPEGR | 686 | Q58F21 | |
| MAPKRKGGLKLNAIC | 21 | Q86V15 | |
| PACQCSSDKIKKMLP | 1461 | O95477 | |
| VLEKGRSKMIACPTK | 441 | Q9BXX3 | |
| LLKANCGMKVSIPTK | 726 | Q9BXX3 | |
| LKAPCRMKVSIPTKA | 846 | Q9BXX3 | |
| PEKKELGCDKMVPNS | 451 | Q9Y485 | |
| KCHLLKRNTKEPPMS | 76 | Q7Z4U5 | |
| KAFTNSKIRKPKMCP | 676 | P01023 | |
| VAKCQLMKTERPKPN | 56 | Q9Y243 | |
| DIMPTARPKRKGKCA | 391 | Q86UN2 | |
| RPATMKGKERSPVKA | 41 | Q96T37 | |
| PGRCLPKSIKTKTQM | 796 | Q5T8P6 | |
| LQKMRSKPATGEPQK | 596 | Q9NW13 | |
| AILCRKGKPMKLTID | 211 | Q8N3J5 | |
| ETLSLNKCPDKMPKR | 6 | Q96M98 | |
| NKCPDKMPKRTKLLA | 11 | Q96M98 | |
| CKQCPPMKKGVSYLL | 386 | Q15113 | |
| AMPEKAKCPTLEITK | 6 | A0A1B0GVH7 | |
| KRMKEAPQTCKLPGQ | 251 | O60890 | |
| CNVKSPSKMPEINAK | 86 | Q15011 | |
| KMISLCLQKDPEKRP | 266 | O95747 | |
| PMKTIVRGNKPCKET | 66 | Q9P286 | |
| VCALKPKADAKLGMP | 151 | Q9BYB4 | |
| PKADAKLGMPMCLRL | 156 | Q9BYB4 | |
| KELRKMVTKCPNNSG | 901 | P08235 | |
| LLNCKMPPAEKASRI | 1006 | Q14676 | |
| KCRKINGMVGLVPKN | 231 | P16333 | |
| QSLKVMPCLAPIAAK | 3006 | Q8IWI9 | |
| RLRKMSVKGATPKPE | 376 | Q86UW9 | |
| LPKGPTCCSRKMEEK | 66 | P51654 | |
| PALVKKRMPDACTLG | 36 | Q6ZUU3 | |
| RDKSCKLPIPKGSMG | 41 | Q9NR63 | |
| LSVCPMVPKDLGKSL | 816 | Q9NR82 | |
| AAAKPKTMPKERAIC | 451 | Q9UPA5 | |
| KSSPCMVRKQDKPLP | 531 | Q13191 | |
| KMFLRRSKLPKNCPP | 276 | Q5JST6 | |
| MEKANPKTGPTLRKE | 146 | Q9H2K0 | |
| NTLDVMKKPRCGVPD | 86 | P45452 | |
| TCAEKLKKRMQGPIP | 201 | O14733 | |
| KTAMKKLRIKPCGIP | 296 | Q8NH05 | |
| MLLTNGQKAKCGPKL | 1871 | O15018 | |
| VFKGLCKIPPSQKLM | 391 | P31512 | |
| VGAMPGKIIQCLKKT | 566 | P36776 | |
| CTMVEKRVLALPGKP | 386 | P05771 | |
| KDCPTPMGTKGKKQL | 156 | P23219 | |
| CKKAQPKEVMSPTGS | 181 | O43347 | |
| SIMKNCIGKELSKIP | 421 | P22059 | |
| PRKKPFECGSEMRKA | 411 | Q9GZU2 | |
| PNKMKTVKCAPGVDV | 46 | O95274 | |
| MEIPGSLCKKVKLSN | 1 | O43252 | |
| EQKKLMAPGCEPLTV | 991 | Q8N0W3 | |
| KSEKNKPLDPEMQCL | 276 | P57057 | |
| CEANKKPKPIRRMCN | 886 | O15072 | |
| RDPPSKKRKMENCAQ | 221 | O43313 | |
| MAPKTKKGCKVTLPE | 1 | Q8TES7 | |
| MLLFIPGCKTPDQLK | 91 | Q9BVC3 | |
| KLEEMLGCKTPIGKP | 661 | O15228 | |
| SICIMKGMKPERKPD | 2801 | Q8TD57 | |
| DCVSKKQMPPVGSKK | 471 | Q03188 | |
| KPLEIKTQCSGPRMD | 176 | Q86TI2 | |
| KPKMLKCSNRKSLSP | 456 | Q9HC77 | |
| TVVRFKVPGMKPDCK | 86 | Q6B9Z1 | |
| KRRGVKASPCMKPAP | 1121 | Q3T8J9 | |
| KFTEKPRPGVQMLCS | 316 | Q9NSI6 | |
| MKGCIKVLKDQPPNS | 281 | Q9NUQ9 | |
| KKNSTFIPRKPMKCS | 1091 | Q5T890 | |
| LKRGLKPSCTIIPLM | 771 | P49327 | |
| ARRKKKMSPPCISVE | 2181 | O95180 | |
| GKMLCSKILEKTANP | 426 | O75923 | |
| RMPKPAKTAKKCSLD | 1931 | O75923 | |
| KGSKVMPNIEKLRSC | 181 | Q13822 | |
| KPKSMQCKVILLDGS | 106 | Q9Y2J2 | |
| MKRRTDPECTAPIKK | 1 | Q8N1G2 | |
| LDVRVPSKPCLMKQK | 131 | Q8N4N8 | |
| AQRSPDKKTCPMKEG | 131 | Q9H488 | |
| TMNVIKKPRCGVPDV | 91 | O60882 | |
| RKKDLRISCMSKPPA | 21 | P46734 | |
| PKGLTKVNICMSRIK | 91 | Q9NP80 | |
| MGAPALKICDKPAKV | 1521 | Q9NQT8 | |
| SNMSVPKKMCKRPCI | 921 | Q9BQF6 | |
| KMRSGKMAPKPQSRC | 496 | Q96N64 | |
| CVERKAKLMTPNGPE | 71 | O75324 | |
| GLVKTISCKPLAMPK | 181 | Q8IYX7 | |
| SKKMPKIPVLVSCED | 196 | Q9Y4C2 | |
| PMFLCIKVGKPMRKS | 656 | Q8NI08 | |
| AETLKVMKQPRCGVP | 81 | P03956 | |
| RNKMKDIPKRPFSQC | 361 | Q9Y6E0 | |
| TCVIGLNKDLKMPKV | 786 | Q99460 | |
| MKRRNKIQPCLSKPA | 36 | Q9Y274 | |
| KQLIKCMPSEPETIK | 1411 | Q7Z333 | |
| KVIVMPTTKEKCPRC | 976 | Q9NSE4 | |
| SMKKLTRKQGDLQPP | 346 | B9A6J9 | |
| LLPKMKTVCPLCRKT | 296 | O00623 | |
| LLSPMRDAPCLLKTK | 101 | Q13438 | |
| KKCVGLELSKITMPI | 81 | Q9H1P3 | |
| PPLVMGLKLDFCASK | 156 | A6NF89 | |
| KNSKCPEGTKPMLIF | 131 | Q9H7B2 | |
| TVLICGNFKGMKIKP | 381 | Q53FZ2 | |
| ECISSAMPKKKKPSR | 2041 | P25054 | |
| KCAMINIKPGELPKE | 391 | Q96M20 | |
| KRNKKPVEDCPRMKG | 131 | O60810 | |
| VCQKEPGKPRMVKSV | 191 | Q8IXZ2 | |
| KKRKIKDMLNTPLCP | 281 | Q96LT9 | |
| KGLKKTCVTMDQERP | 21 | Q4G0A6 | |
| EKNKIPKDSMTLLPC | 6 | Q6T4P5 | |
| KLPPCTDMKSKVRQR | 66 | A6NCN8 | |
| KSLKVGMIPAPKRVC | 956 | Q8IX01 | |
| KLMPGRQAKDPECKT | 2206 | Q6ZS81 | |
| CTKVLKPMQPKALVC | 1996 | Q9HCK1 | |
| KPMQPKALVCVLSSL | 2001 | Q9HCK1 | |
| PILAMPGRNKAKSTC | 46 | O43847 | |
| LPREMMPRNKCKKAG | 106 | O15318 | |
| GQENPKVLKKMTPCV | 286 | Q68DE3 | |
| CLPNMKSKRLNKKPG | 786 | Q68DE3 | |
| MERPLEKPSCSLGIK | 1206 | Q68DE3 | |
| PKPTKGKMRIHCLEN | 101 | P11277 | |
| VPIPLGSKNNMCIKR | 101 | Q9NYK1 | |
| LDPGCPSREMQKLLK | 511 | Q96AP4 | |
| PDMQSRCQTKKLLPK | 76 | Q6PG37 | |
| PRRKAKMLPKNCSLL | 131 | Q05066 | |
| KCMDKPGPKLDSRAE | 46 | O60220 | |
| TPRKNKAAMCKPLMQ | 826 | Q14202 | |
| GQSKRLAVPCKLEKM | 266 | Q9H808 | |
| MAPIPKTVGRIKLDC | 1 | Q49AM3 | |
| NKPAVKMCIDPSLSV | 316 | Q9P2D8 | |
| NVKPKPKLKECSMDP | 386 | P82987 | |
| KMVPNGLDILKCPVS | 1166 | P35573 | |
| GNKPPSKTCLKEEMA | 16 | Q03721 | |
| GFCLMLQVSAKRPPK | 21 | Q8N145 | |
| SCGALQVKMKPKITR | 111 | O15146 |